Most individuals with hoarseness are usually experiencing benign disease such as an acute top respiratory tract infection. They could be treated with suitable antibiotics, voice rest, inhalations of eucalyptus and menthol, and adequate hydration. Every attempt should be made to improve the wellness of the upper respiratory tract by managing sinus disease and any gastro-oesophageal reflux. The proton pump inhibitor has been a giant leap forward in the treating laryngeal disorders secondary to oesophageal reflux. GPs may need to consider modifying the management of conditions such as hypertension, respiratory allergy or osteoporosis if medications are adding to intolerable vocal symptoms.. A practical method of managing hoarseness The voice is among the unique characteristics of human beings and is of vital importance in communication... Adeona completes $1 million equity financing and provides revise on Zinthionein ZC clinical study Adeona Pharmaceuticals, Inc., announced today that on July 6, 2010, it completed an equity financing of $1 million with a single institutional investor, 88 Seaside, L.P.32 per share. Individually, Adeona announced the completion of 75 percent enrollment in Part 2 of Adeona’s 60 patient clinical research of oral Zinthionein ZC for Alzheimer’s disease and slight cognitive impairment entitled, A Potential, Randomized, Double Blind Trial of a Novel Oral Zinc Cysteine Preparation in Alzheimer’s Disease . The CopperProof-2 research represents the initial controlled clinical study of oral zinc therapy for Alzheimer’s disease and moderate cognitive impairment.